Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

INOVIQ - Appendix 4D and FY24 Half Year Financial Report (ASX:IIQ)

To view the appendix, download the attached PDF.

INOVIQ detects 19% more breast cancers than leading test (ASX:IIQ)

INOVIQ Limited (ASX:IIQ or INOVIQ) is excited to announce the successful completion of its breast cancer study. In a 2023 clinical validation study (n=483), INOVIQ’s SubB2M/CA15-3 test dete...read more

INOVIQ - Trading Halt (ASX:IIQ)

Description The securities of INOVIQ Ltd (‘IIQ’) will be placed in trading halt at the request of IIQ, pending it releasing an announcement. Unless ASX decides otherwise, the sec...read more

INOVIQ - Appendix 4C and Quarterly Activities Report - December 2023 (ASX:IIQ)

“Those who know me from my role as Chairman of PolyNovo (ASX: PNV), know how excited I am to lead a company dedicated to saving lives and improving patient outcomes. We all have family and fri...read more

INOVIQ - 2023 AGM CEO Presentation (ASX:IIQ)

To view the presentation, download the attached PDF.

INOVIQ - Bell Potter Healthcare Conference Investor Presentation (ASX:IIQ)

To view the presentation, download the attached PDF.

INOVIQ - ANSEV Meeting Presentations (ASX:IIQ)

Melbourne, Australia, 8 November 2023: INOVIQ Limited (ASX:IIQ) today advises that it will present new data on the effectiveness and utility of its proprietary exosome isolation technology, EXO-NET&...read more

INOVIQ - Appendix 4C and Quarterly Activities Report - September 2023 (ASX:IIQ)

-- INOVIQ and Promega sign a global joint marketing agreement for INOVIQ’s EXO-NET® exosome capture technology and Promega Nucleic Acid purification systems -- INOVIQ and ResearchDx sign ...read more

INOVIQ - ASX Small and Mid-Cap Conference Investor Presentation (ASX:IIQ)

To view the presentation, download the attached PDF.

INOVIQ and ResearchDx sign USA EXO-NET Services Agreement (ASX:IIQ)

INOVIQ and ResearchDx sign a license and supply agreement for INOVIQ’s EXO-NET® pan-exosome capture product to provide EXO-NET services in the USA ResearchDx Inc is a...read more

INOVIQ - Appendix 4E and Preliminary Financial Report (ASX:IIQ)

To view the Appendix 4E and Preliminary Financial Report, download the attached PDF.

INOVIQ - EXO-OC Program Completes Serum Equivalence Study (ASX:IIQ)

Serum equivalence study confirms EXO-NET isolates extracellular vesicles (EVs) from both plasma and serum samples- enables access to large ovarian cancer serum biobanks for further research ...read more

INOVIQ - INOVIQ Investor Briefing (ASX:IIQ)

To view the Investor Briefing, download the attached PDF.

INOVIQ - Appendix 4C and Quarterly Activities Report - June 2023 (ASX:IIQ)

Highlights: -- Positive clinical data demonstrating SubB2M/CA15-3 test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) -- Post quarter ...read more

INOVIQ and Promega announce Global Joint Marketing Agreement (ASX:IIQ)

Melbourne, Australia and Madison, WI USA, 6 July 2023: INOVIQ Limited (ASX:IIQ) (INOVIQ), an innovative developer of exosome solutions and precision diagnostics, and Promega Corporation (Promega), a...read more

Viewing: 16 - 30 of 111 Previous | Next